Rare disease

Focal Segmental Glomerulosclerosis

Clinical trials recruiting in Australia for Focal Segmental Glomerulosclerosis, a rare disease, as the public registries list them.

Also called: FSGS; Focal and segmental glomerulosclerosis; Focal glomerulosclerosis; Focal glomerular sclerosis; Focal and segmental glomerular sclerosis

Follow this condition Browse A to Z Browse by body system

Sources: ClinicalTrials.gov Checked: 15 October 2026 Not medical advice

At a glance

5 trials recruiting in Australia

30 trials recruiting overseas

Not recorded prevalence

Not recorded age of onset

15 October 2026 date last checked

Trials in Australia

This Australian count is likely to be on the low side. It counts the trials this site files under this condition; the registry’s own search is broader and also returns closely related conditions, some of which have their own page here. If you are searching widely, check the registry as well — every trial below links to its own record.

Recruiting Phase 3

Phase 3 study for people with Focal Segmental Glomerulosclerosis
Where
No Australian site on this record is listed as recruiting right now, even though the trial itself is open. Check with the site or the official record before travelling.
- Griffith University, Brisbane — Active not recruiting
- Princess Alexandra Hospital, Brisbane — Active not recruiting
- Austin Hospital, Melbourne — Active not recruiting
- Monash Health, Melbourne — Active not recruiting
- St Vincent's Hospital Melbourne, Melbourne — Active not recruiting
- Western Health, Melbourne — Active not recruiting
- John Hunter Hospital, Sydney — Active not recruiting
- Liverpool Hospital, Sydney — Active not recruiting
- Nepean Hospital, Sydney — Active not recruiting
- Royal North Shore Hospital, Sydney — Active not recruiting
Who can join Age 12 Years to 80 Years. Sex Anyone, regardless of sex. Healthy volunteers Not accepted.

Sponsor Dimerix Bioscience Pty Ltd

Timeline

Started 30 May 2022 Today 16 October 2026 Estimated completion 1 December 2029
NCT05183646 · Checked 11 October 2026

Trial details Summary for your GP Official record and contacts
Recruiting Phase 2

Phase 2 study for people with Focal Segmental Glomerulosclerosis
Where
- Westmead Hospital, Westmead (NSW) — Recruiting
- Western Health Sunshine Hospital, St Albans (VIC) — Recruiting
Who can join Age 18 Years to 75 Years. Sex Anyone, regardless of sex. Healthy volunteers Not accepted.

Sponsor Walden Biosciences

Timeline

Started 2 July 2024 Today 16 October 2026 Estimated completion 1 March 2027
NCT06466135 · Checked 11 October 2026

Trial details Summary for your GP Official record and contacts
Recruiting Phase 2

Phase 2 study for people with Focal Segmental Glomerulosclerosis
Where
- Investigational Site Number : 0360003, Garran (ACT) — Recruiting
- Investigational Site Number : 0360001, Parkville (VIC) — Recruiting
Who can join Age 16 Years to 75 Years. Sex Anyone, regardless of sex. Healthy volunteers Not accepted.

Sponsor Sanofi

Timeline

Started 19 December 2024 Today 16 October 2026 Estimated completion 23 December 2026
NCT06500702 · Checked 11 October 2026

Trial details Summary for your GP Official record and contacts
Recruiting Phase 3

Phase 3 study for people with Focal Segmental Glomerulosclerosis
Where
- Concord Repatriation General Hospital, Concord (NSW) — Not yet recruiting
- Nepean Hospital, Kingswood (NSW) — Recruiting
- St George Hospital, Kogarah (NSW) — Recruiting
- The Children's Hospital at Westmead, Westmead (NSW) — Not yet recruiting
- Royal Brisbane and Women's Hospital, Herston (QLD) — Recruiting
- Griffith Health, Southport (QLD) — Recruiting
- Royal Adelaide Hospital, Adelaide (SA) — Recruiting
- Sunshine Hospital, AT Albans (VIC) — Not yet recruiting
- Royal Melbourne Hospital, Parkville (VIC) — Recruiting
Who can join Age 12 Years and over. Sex Anyone, regardless of sex. Healthy volunteers Not accepted.

Sponsor Boehringer Ingelheim

Timeline

Started 16 February 2026 Today 16 October 2026 Estimated completion 27 December 2028
NCT07220083 · Checked 15 October 2026

Trial details Summary for your GP Official record and contacts
Recruiting Phase 1

Phase 1 study for people with Focal Segmental Glomerulosclerosis
Where
- Q-Pharm Pty Ltd., Herston (QLD) — Recruiting
Who can join Age 18 Years to 55 Years. Sex Anyone, regardless of sex. Healthy volunteers Accepted.

Sponsor Consun Pharmaceutical Group

Timeline

Started 8 December 2025 Today 16 October 2026 Estimated completion 30 April 2027
NCT07267026 · Checked 11 October 2026

Trial details Summary for your GP Official record and contacts

Trials overseas

30 trials for this disease are open to new participants outside Australia, as ClinicalTrials.gov listed them on 11 October 2026. Voxsanity does not publish a page for any of them; the searches below reach them at the registry.

These overseas counts are likely too high. They come from the registry’s own search, which expands a condition name to related conditions, so some of the trials counted are for a different disease in the same family.

Search ClinicalTrials.gov Search the WHO registry portal Joining a trial overseas

Trials not shown here

Some Australian trials are registered only on the Australian New Zealand Clinical Trials Registry and are not shown here. Search them at Australian Clinical Trials.

Key facts

Inheritance Not recorded

Genes Not recorded

Prevalence Not recorded

Age of onset Not recorded

Orphadata Science: Free access data from Orphanet. © INSERM 1999. Available on https://www.orphadata.com. Used under CC BY 4.0. Source: Orphanet / Orphadata (orphadata.com).

Sources and dates

ClinicalTrials.gov – trial records, statuses and site lists
ClinicalTrials.gov processing date: 14 October 2026.
This page last checked by Voxsanity: 15 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Focal Segmental Glomerulosclerosis is one of the rare diseases tracked on the Voxsanity rare disease hub, where you can compare it with every other rare condition we follow and filter trials by country.

Tell us which conditions matter to you

We use requests to help decide what to add next. Telling us about a condition is not a promise that we will add it, and we cannot say when any condition might appear.